Source: Eur Respir J 2010; 35: 960-968



Rating:

Share or cite this content

Citations should be made in the following way:
Miravitlles M., Herr C., Ferrarotti I., Jardi R., Rodriguez-Frias F., Luisetti M., Bals R.. Laboratory testing of individuals with severe α1-antitrypsin deficiency in three European centres. Eur Respir J 2010; 35: 960-968

Member's Comments

No comment yet.

Related content which might interest you: Screening for α1-Pi deficiency in patients with lung diseases Source: Eur Respir J 2002; 20: 319-324 Year: 2002 Results of a case-detection programme for α1-antitrypsin deficiency in COPD patients Source: Eur Respir J 2005; 26: 616-622 Year: 2005 Prevalence of vitamin D deficiency in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Smoke exposure as a determinant of autoantibody titre in alpha 1-antitrypsin deficiency and COPD Source: Eur Respir J 2011; 37: 32-38 Year: 2011 Rate of progression of lung function impairment in α1-antitrypsin deficiency Source: Eur Respir J 2009; 33: 1338-1344 Year: 2009 Desmosin as a marker for tissue injury in COPD Source: Annual Congress 2007 - α1-Antitrypsin deficiency: molecular and clinical news Year: 2007 Iron deficiency as a novel biomarker of functional impairment in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - Physiological basis of respiratory disease Year: 2011 The minimal important difference of exercise tests in severe COPD Source: Eur Respir J 2011; 37: 784-790 Year: 2011 Determinants of success Source: Eur Respir J 2011; 38: 1215-1218 Year: 2011 Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 903-908 Year: 2001 The prognostic importance of the protease-antiprotease imbalance in development of chronic obstructive pulmonary disease comorbid with chronic pancreatitis Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Distinct clinical phenotypes of airways disease defined by cluster analysis Source: Eur Respir J 2009; 34: 812-818 Year: 2009 Epidemiology of chronic obstructive pulmonary disease Source: Eur Respir J 2001; 17: 982-994 Year: 2001 The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Detection of chronic obstructive pulmonary disease (COPD) in patients with cardio-vascular system pathology Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Prognostic value of C-reactive protein in patients with severe to very severe chronic obstructive pulmonary disease Source: Annual Congress 2006 - COPD and inflammation Year: 2006 Improvement of diagnosis and treatment of obstructive lung diseases with a one stop diagnostic consultancy Source: Annual Congress 2006 - COPD – the challenges for primary care Year: 2006 Clinical determinants of exacerbations in severe, early-onset COPD Source: Eur Respir J 2007; 30: 1124-1130 Year: 2007 The potential impact of anaemia of chronic disease in COPD Source: Eur Respir J 2006; 27: 390-396 Year: 2006